Rapport Therapeutics develops small molecule drugs for neurological and psychiatric disorders, led by a candidate for focal onset seizures. It last closed at $23.76 on Nov 17, down 4.27% on the day. The average 12-month price target from 6 analysts is $64.00 (+169.4% from the last close), with a high of $82.00 and a low of $47.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). In the past 30 days there were 2 dark pool prints totaling $2.1M, the largest $1.2M.
Each firm's latest rating on RAPP in the past 90 days
Average 12-month target
$64.00
▲ 169.4% upside
Based on 6 analysts who set a price target on RAPP in the past 90 days. The average target is $64.00, with a high of $82.00 and a low of $47.00, compared with the last close of $23.76.
Low $47.00Avg $64.00High $82.00
Blue marker: last close $23.76
Highest target$82.00
Average target$64.00
Lowest target$47.00
Latest rating changes
UBSTarget lowered
Nov 6Buy$71 → $64
GuggenheimTarget lowered
Nov 5Buy$70 → $66
Wells FargoTarget lowered
Nov 5Buy$50 → $47
Jones TradingMaintained
Oct 21Buy$82
Wells FargoMaintained
Oct 21Buy$50
Date
Firm
Action
Rating
Price target
Nov 6
UBS
Target lowered
Buy
$71 → $64
Nov 5
Guggenheim
Target lowered
Buy
$70 → $66
Nov 5
Wells Fargo
Target lowered
Buy
$50 → $47
Oct 21
Jones Trading
Maintained
Buy
$82
Oct 21
Wells Fargo
Maintained
Buy
$50
Loading…
Technical Analysis
RAPP · as of the Nov 17 close · updated after every close
Downtrend
The stock is 7% below its 20 day and 31% below its 50 day average. It is 50% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 38). The nearest support is the Pivot S1 at $23.19, and the nearest resistance the Pivot at $23.98.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 8.4%/day
Key levels
$52.9352 week high+122.8%
$37.74100 day average+58.8%
$35.56200 day average+49.7%
$31.0650 day average+30.7%
$26.36Swing high (Nov 4)+10.9%
$25.3220 day average+6.6%
$24.55Pivot R1+3.3%
$23.98Pivot+0.9%
$23.76Last close
$23.19Pivot S1−2.4%
$22.95Swing low (Nov 6)−3.4%
$22.0652 week low−7.2%
Indicators
RSI (14)
38.45
Weak, oversold below 30
Neutral
MACD
-1.60
Above its signal line
Bullish
Stochastic
49.1
Middle of its range
Neutral
ADX (14)
30.5
Trending down
Williams %R
-72.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-107.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−6.6%
Change over 10 sessions
Bearish
ATR (14)
$2.01
Typical daily range, 8.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 19.4%/day
Key levels
$52.9352 week high+122.8%
$37.74100 day average+58.8%
$35.56200 day average+49.7%
$31.0650 day average+30.7%
$26.36Swing high (Nov 4)+10.9%
$25.3220 day average+6.6%
$24.55Pivot R1+3.3%
$23.98Pivot+0.9%
$23.76Last close
$23.19Pivot S1−2.4%
$22.95Swing low (Nov 6)−3.4%
$22.0652 week low−7.2%
Indicators
RSI (14)
31.66
Weak, oversold below 30
Neutral
MACD
-3.27
Below its signal line
Bearish
Stochastic
8.8
Near the bottom of its range
Oversold
ADX (14)
35.5
Trending down
Williams %R
-94.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-107.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−45.5%
Change over 10 sessions
Bearish
ATR (14)
$4.62
Typical daily range, 19.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for RAPP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RAPP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in RAPP in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RAPP is in one of them and how their past RAPP trades turned out.
Rapport Therapeutics is a biotechnology company based in Boston, Massachusetts, that develops small molecule drugs for neurological and psychiatric disorders. Its lead candidate, RAP-219, is being studied for focal onset seizures, a form of epilepsy, and is also being evaluated for generalized seizures and bipolar mania. The company is also developing an injectable version of that candidate and earlier-stage programs aimed at chronic pain, migraine, and hearing and balance disorders. Its intended market is patients with these conditions and the physicians who treat them.